-
Phase 3 TALAPRO-2 data of talazoparib plus enzalutamide published in The Lancet
18 Jul 2025 22:51 GMT
… ’s primary analysis, time to prostate-specific antigen (PSA) progression, time to initiation …
-
Enrollment goal met in trial of 64Cu-SAR-bisPSMA vs. 68Ga-PSMA-11 PET/CT
18 Jul 2025 14:58 GMT
… patient group with such low [prostate-specific antigen] PSA, this may improve image …
-
The six health checks every man needs to book now
18 Jul 2025 14:42 GMT
… the age of 50, a Prostate-Specific Antigen (PSA) test should be conducted …
-
Trading Floor: Car Group slides, Clarity gains, Ionic up
18 Jul 2025 04:31 GMT
… recurrence in patients with low prostate-specific antigen (PSA) levels who are candidates …
-
How to get TRT in 2025: A step-by-step guide to optimizing your testosterone levels
18 Jul 2025 04:06 GMT
… hormone-binding globulin (SHBG), the prostate-specific antigen (PSA), and other hormones that …
-
Co-PSMA trial: Recruitment successfully completed
17 Jul 2025 15:04 GMT
… recurrence in patients with low prostate-specific antigen (PSA) who are candidates for …
-
Cancer-hit ex-Sky News star Dermot Murnaghan reveals how he ‘fell through gaps’ before stage 4 diagnosis
17 Jul 2025 09:05 GMT
… weren’t testing for PSA (prostate-specific antigen).
“I never went to my …
-
Outpatient Procedure Provides New Option for Prostate Cancer
17 Jul 2025 05:17 GMT
… July 2023, following a routine prostate-specific antigen (PSA) blood test as part …
-
Health Check: Immuron shares bust out for a ‘run’ on strong Travelan sales
17 Jul 2025 02:55 GMT
… study enrols patients with low prostate-specific antigen (PSA).
These patients are candidates …
-
Carotuximab/Apalutamide Shows Tolerability in Metastatic CRPC
17 Jul 2025 00:56 GMT
… history of CRPC with rising prostate-specific antigen (PSA) on a contemporary androgen …